Ahlcon Parenterals India Ltd has been delisted from the stock exchange.
Sector
PharmaceuticalsOpen
₹515Prev. Close
₹516Turnover(Lac.)
₹151.93Day's High
₹516.75Day's Low
₹514.7552 Week's High
₹052 Week's Low
₹0Book Value
₹-214.98Face Value
₹10Mkt Cap (₹ Cr.)
370.8P/E
0EPS
0Divi. Yield
0No Record Found
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 191.92 | 6.92 | 7.2 | 7.2 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -161.99 | -153.78 | -131.12 | -123.13 |
Net Worth | 29.93 | -146.86 | -123.92 | -115.93 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2017 | Mar-2016 | Mar-2015 | Mar-2014 |
|---|---|---|---|---|
Revenue | 135.38 | 118.99 | 115.98 | 119.96 |
yoy growth (%) | 13.77 | 2.59 | -3.32 | 11.38 |
Raw materials | -46.44 | -40.62 | -41.17 | -41.5 |
As % of sales | 34.3 | 34.14 | 35.5 | 34.59 |
Employee costs | -24.56 | -22.44 | -17.67 | -15.88 |
| Y/e 31 Mar( In .Cr) | Mar-2017 | Mar-2016 | Mar-2015 | Mar-2014 |
|---|---|---|---|---|
Profit before tax | -13.82 | -23.77 | 20.88 | 30.06 |
Depreciation | -16.3 | -16.12 | -4.6 | -3.44 |
Tax paid | 0 | 5.23 | -3.87 | -10.55 |
Working capital | 6.71 | 0.76 | -24.6 | 19.6 |
Other operating items |
| Y/e 31 Mar | Mar-2017 | Mar-2016 | Mar-2015 | Mar-2014 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 13.77 | 2.59 | -3.32 | 11.38 |
Op profit growth | 125.32 | -66.95 | -25.82 | 42.48 |
EBIT growth | -148.19 | -133.47 | -32 | 46.22 |
Net profit growth | -25.41 | -208.91 | -12.75 | 51.55 |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,845.2 | 101.44 | 4,42,725.29 | 608.7 | 0.87 | 4,887.27 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,885 | 71.05 | 1,82,775.12 | 756 | 0.43 | 2,793 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,484.15 | 67.95 | 1,51,764.01 | 467 | 0.13 | 2,677 | 249.82 |
Cipla Ltd CIPLA | 1,398.95 | 30.54 | 1,13,007.26 | 384.64 | 0.93 | 3,840.92 | 423.38 |
Dr Reddys Laboratories Ltd DRREDDY | 1,307.1 | 33.88 | 1,09,098.01 | -219.4 | 0.61 | 3,802.6 | 375.78 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Aditya Kumar Banerjee
Whole-time Director
Navin Hans
Director
Eva Fatima Maegerlein
Company Secretary / Compliance Officer
Ranjan Kumar Sahu
201-205 2nd Flr of ND Mall-1,
Plot 2-4 Netaji Subhash Place,
Delhi - 110034
Tel: 91-11-42344234
Website: http://www.ahlconindia.com
Email: ranjan.sahu@ahlconindia.com
T-34 2nd Floor,
Okhla Industrial Are, Phase II,
New Delhi - 110020
Tel: 91-011-26387281/83
Website: www.masserv.com
Email: info@massere.com
Summary
Earlier known as Gujarat Inject, the company was incorporated on 20 Jan.92. It has been promoted by Ahluwalia Contracts and Bikramjit Ahluwalia.It manufactures and markets IV fluids. Intravenous fluid...
Read More
Reports by Ahlcon Parenterals India Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.